Vascular risk factors and Alzheimer's disease

REFERENCES

• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E M. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• Roman G C, Tatemichi T K, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NBSfDS-AIREN International Workshop. Neurology 1993; 43: 1609–1611
   PubMed Web of Science ®Google Scholar
• McKeith I G, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 1996; 47: 1113–1124
   PubMed Web of Science ®Google Scholar
• Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. British Journal of Psychiatry 1999; 174: 45–50
   PubMed Web of Science ®Google Scholar
• Kokman E, Whistman J P, O'Fallon W M, Chu C P, Beard C M. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 1996; 19: 154–159
   Web of Science ®Google Scholar
• Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45: 1161–1168
   PubMed Web of Science ®Google Scholar
• Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 1994; 44: 97–104
   PubMed Web of Science ®Google Scholar
• Ott A, Breteler M MB, de Bruyne M C, van Harskamp F, Grobee D E, Hofman A. A trial fibrillation and dementia in a population-based study. Stroke 1997; 28: 316–321
   PubMed Web of Science ®Google Scholar
• Hofman A, Ott A, Breteler M MB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151–154
   PubMed Web of Science ®Google Scholar
• van Duijn C M. Genetic and environmental factors and the incidence of Alzheimer's disease. Neurobiology of Aging 1998; 19: 8227
   Web of Science ®Google Scholar
• Farmer M E, White L R, Abbott R D, et al. Blood pressure and cognitive performance: the Framingham Study. American Journal of Epidemiology 1987; 126: 1103–1114
   PubMed Web of Science ®Google Scholar
• Launer L J, Masaki K, Petrovitch H, Foley D, Havlik R J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. Journal of the American Medical Association 1995; 274: 1846–1851
   PubMed Web of Science ®Google Scholar
• Kuusisto J, Koivisto K, Mykkanen L, et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. British Medical Journal 1997; 315: 1045–1049
   PubMed Web of Science ®Google Scholar
• Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. British Medical Journal 1996; 312: 805–80
   PubMed Web of Science ®Google Scholar
• Katzman R, Aronson M, Fuld P, et al. Development of dementing illness in an 80-year-old volunteer cohort. Annals of Neurology 1989; 25: 317–324
   PubMed Web of Science ®Google Scholar
• Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141–1145
   PubMed Web of Science ®Google Scholar
• Forette F, Seux M-L, Staessen J A, et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347–1351
   PubMed Web of Science ®Google Scholar
• Prince M J, Bird A S, Blizard R A, Mann A H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. British Medical Journal 1996; 312: 801–805
   PubMed Web of Science ®Google Scholar
• Applegate W B, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Archives of Internal Medicine 1994; 154: 2154–2160
   PubMed Web of Science ®Google Scholar
• Ott A, Stolk R P, Hofman A, van Harskamp F, Grobbee D E, Breteler M MB. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996; 39: 1392–1397
   PubMed Web of Science ®Google Scholar
• Ott A, Stolk R P, van Harskamp F, Breteler M MB. Diabetes mellitus and the risk of dementia in an elderly population. Risk of Dementia. The Rotterdam Study, A Ott. Judels En Brinkman BV, Delft 1997; 49–62
   Google Scholar
• Reaven G M. Role of Insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Prince M J. Vascular risk factors and atherosclerosis as risk factors for cognitive decline and dementia. Journal of Psychosomatic Research 1995; 39: 525–530
   PubMed Web of Science ®Google Scholar
• Riggs J E. Smoking and Alzheimer's disease: protective effect or differential survival bias?. Lancet 1993; 342: 793–794
   PubMed Web of Science ®Google Scholar
• Canadian Study of Health and Aging. Risk factors for Alzheimer's disease in Canada. Neurology 1994; 44: 2073–2080
   PubMed Web of Science ®Google Scholar
• Ott A, Slooter A JC, Hofman A. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998; 351: 1840–1843
   PubMed Web of Science ®Google Scholar
• Notkola I, Sulkava R, Pekkanen J. Serum total cholesterol, apolipoprotein E ϵ4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17: 14–20
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Launer L J, Ott A. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology 1997; 42: 776–782
   PubMed Web of Science ®Google Scholar
• Marin D B, Breuer B, Marin M L, et al. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 1998; 140: 173–180
   PubMed Web of Science ®Google Scholar
• Prince M, Lovestone S, Cervilla J, Mann A. The association between ApoE and dementia is mediated neither by vascular disease nor its risk factors in an aged cohort of survivors with hypertension. Neurology, (in press)
   Web of Science ®Google Scholar
• Tang M X, Maestre G, Tsai W Y, et al. Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Annals of the New York Academy of Science 1996; 802: 6–15
   PubMed Web of Science ®Google Scholar
• Itzhaki R F, Lin W, Shang D, Wilcock G K, Faragher B, Jamieson G A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997; 349: 241–244
   PubMed Web of Science ®Google Scholar
• Ukkola O, Kervinen K, Salmela P I, von Dickhoff K, Laakso M, Kesäniemi Y A. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulindependent diabetes mellitus. Atherosclerosis 1993; 101: 9–15
   PubMed Web of Science ®Google Scholar
• Stewart R. Cardiovascular factors in Alzheimer's disease. Journal of Neurology. Neurosurgery and Psychiatry 1998; 65: 143–147
   PubMed Web of Science ®Google Scholar
• Sparks D L, Scheff S W, Liu H, Landers T M, Coyne C M, Hunsaker J C. Increased incidence of neurofibrillary tangles in non-demented individuals with hypertension. Journal of Neurological Science 1995; 131: 162–169
   PubMed Web of Science ®Google Scholar
• Hall E D, Oostveen J A, Dunn E, Carter D B. Increased amyloid protein precursor and apolipoprotein E immuno-reactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Experimental Neurology 1995; 135: 17–27
   PubMed Web of Science ®Google Scholar
• de la Torre J C, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease?. Neurological Research 1993; 15: 146–153
   PubMed Web of Science ®Google Scholar
• Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Medicine 1999; 16: 93–112
   PubMed Web of Science ®Google Scholar
• Snowdon D A, Greiner L H, Mortimer J A, Riley K P, Greiner P A, Markesbery W R. Brain infarction and the clinical expression of Alzheimer disease. Journal of the American Medical Association 1997; 277: 813–817
   PubMed Web of Science ®Google Scholar
• Hoffman R M, Garewal H S. Antioxidants and the prevention of coronary heart disease. Archives of Internal Medicine 1995; 155: 241–246
   PubMedGoogle Scholar
• Markesbery W R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology in Medicine 1997; 23: 134–147
   PubMed Web of Science ®Google Scholar